BioCentury製作的BioCentury This Week
BioCentury
分类: 科學與醫學
新增至我的清單
听听最后一集:
Cross-border geopolitical tensions and a prolonged capital crunch are compelling biopharma companies from Beijing to Boston to rethink their strategies on everything from deal-making and raising capital to manufacturing and use of CROs. On a special edition of the BioCentury This Week podcast, McKinsey’s Franck Le Deu and Wendy Pan of BayHelix and Goodwin join BioCentury on the eve of next week’s eleventh annual BioCentury-BayHelix China Healthcare Summit in Shanghai to discuss the dynamics a...
以前的剧集
-
270 - Ep. 261 - China Summit: Reinventing Your China Strategy Wed, 23 Oct 2024
-
269 - Ep. 260 - VC Funds, New Chapter for MS, Wave's Data Mon, 21 Oct 2024
-
268 - Ep. 259 - Causal Biology and Big Data, Ultra-Rare Drugs at FDA Mon, 14 Oct 2024
-
267 - Ep. 258 - Breaking the Bear: 4Q Public Markets Preview Mon, 07 Oct 2024
-
266 - Ep. 257 - Schizophrenia, Sickle Cell Drugs, D.C. Update Mon, 30 Sep 2024
-
265 - Ep. 256 - ESMO Recap: Keeping TIGIT Alive, Rybrevant & Immunotherapy Anniversary Wed, 25 Sep 2024
-
264 - Ep. 255 - Pediatric PRVs, Biosecure & Novo's Obesity Miss Mon, 23 Sep 2024
-
263 - Ep. 254 - Takeaways from Grand Rounds 2024 Fri, 20 Sep 2024
-
262 - Ep. 253 - IPOs, GLP-1 & Obesity, AI & Biotech Mon, 16 Sep 2024
-
261 - Ep. 252 - Akeso's Bispecific, Vaxcyte & Woodcock's Quality Mindset Mon, 09 Sep 2024
-
260 - Ep. 251 - Eyes on the target: a Back to School Overview Fri, 06 Sep 2024
-
259 - Ep. 250 - Biosecure, Priority Review Vouchers & Target Discovery Wed, 04 Sep 2024
-
258 - Ep. 249 - Biotech IPO Buzz, Pharma Deal Trends, Washington Update Mon, 26 Aug 2024
-
257 - Ep. 248 - Grand Rounds Preview: Eyes on the Target Thu, 22 Aug 2024
-
256 - Ep. 247 - Drug Pricing, Psychedelic Setback & Back to School Mon, 19 Aug 2024
-
255 - Ep. 246 - Wilson’s Vision for Gene Therapy. Plus: Korea Biotech & Grand Rounds Mon, 12 Aug 2024
-
254 - Ep. 245 - Biotech-Academia Deals, Leqembi's Latest, Wilson Moves On Mon, 05 Aug 2024
-
253 - Ep. 244 - Leqembi's Thumbs-Down in Europe. Plus: Perioperative Cancer, Pediatric Review Vouchers Mon, 29 Jul 2024
-
252 - Ep. 243 - Radiopharma Alpha Emitters, AZ’s Galbraith and LNPs Mon, 22 Jul 2024
-
251 - Ep. 242 - 3Q Markets Preview, Washington Update, Lisa Burns Mon, 15 Jul 2024
-
250 - Ep. 241 - U.K. Biopharma on the Move. Plus: IRA, Biosecure Mon, 08 Jul 2024
-
249 - Ep. 240 - Chevron Ruling's Impact. Plus: Tumor Targets, Lurie Winner Mon, 01 Jul 2024
-
248 - Ep. 239 - Rare Disease Spotlight: MPS & DMD Mon, 24 Jun 2024
-
247 - Ep. 238 - Biosecure Act: The Impact & What's Ahead Thu, 20 Jun 2024
-
246 - Ep. 237- Pandemic Prep Problems, Reverse Mergers, Alzheimer’s & SCOTUS Mon, 17 Jun 2024
-
245 - Ep. 236 - BIO Wrap: Biosecure, Japan & Nxera, Radiopharma Thu, 13 Jun 2024
-
244 - Ep. 235 - Psychedelic Setback, FDA's Platform Play & ASCO Innovations Mon, 10 Jun 2024
-
243 - Ep. 234 - Biotech M&A, Biosecure Expands & ASCO Update Mon, 03 Jun 2024
-
242 - Ep. 233 - ASCO Preview, Rare Diseases & Biogen M&A Tue, 28 May 2024
-
241 - Ep. 232 - Shake up at BIO. Plus: ASGCT highlights, new IPF & obesity data Mon, 20 May 2024
-
240 - Bonus Content - Derek Lowe Unplugged: AI; Biosecure; FDA, Abortion & SCOTUS; and more Thu, 16 May 2024
-
239 - Ep. 231 - Biosecure Revised. Plus: Venture Rounds, Deals of Note Mon, 13 May 2024
-
238 - Bonus Content - Ysios' Karen Wagner: How Europe's Biotechs Can Rise Above the Noise Thu, 09 May 2024
-
237 - Ep. 230 - Bio€quity Europe 2024 Preview Wed, 08 May 2024
-
236 - Ep. 229 - ASGCT Preview, Accelerated Approval Plus: The Latest in Biosecure Mon, 06 May 2024
-
235 - Ep. 228 - Energizing Gene Therapy. Plus: AI Newco, Ono-Deciphera Mon, 29 Apr 2024
-
234 - Ep. 227 - Defending Accelerated Approval. Plus: Endpoint Innovation & AIM Amiss Mon, 22 Apr 2024
-
233 - Ep. 226 - Vertex’s Alpine Buy, Goldman’s Venture & IRA Tea Leaves Mon, 15 Apr 2024
-
232 - Ep. 225 - 2Q Markets Preview & AACR Takeaways Mon, 08 Apr 2024
-
231 - Ep. 224 - Biotech IPOs, Avalon & FDA at SCOTUS Mon, 01 Apr 2024
-
230 - Ep. 223 - Biosecure, Bruce Booth & Ultrarare Drugs Mon, 25 Mar 2024
-
229 - Ep. 222 - Crowley’s Vision for BIO, Plus: MASH & CAR Ts Mon, 18 Mar 2024
-
228 - Ep. 221 - China Biocontroversy, Plus: Diversity Matters Mon, 11 Mar 2024
-
227 - Ep. 220 - Biotech’s Financing Flurry & Distillery Spotlight Mon, 04 Mar 2024
-
226 - Ep. 219 - East-West Summit Preview Tue, 27 Feb 2024
-
225 - Ep. 218 - Bob Nelsen Insights, TL1A, Rare Diseases Mon, 26 Feb 2024
-
224 - Ep. 217 - Safer CAR Ts & World’s First TIL Therapy Tue, 20 Feb 2024
-
223 - Ep. 216 - Anti-China Biotech Policy: Biosecure & Beyond Thu, 15 Feb 2024
-
222 - Ep. 215 - ADCs, Psychedelics & IPOs Mon, 12 Feb 2024
-
221 - Ep. 214 - BMS’s Patent Cliff, Congress Targets China Biotech Mon, 05 Feb 2024
显示更多剧集
5